Markets Have Just Experienced AI Shake as Kimi K3 Debuts
Moonshot AI unveils the Kimi K3 model, sparking a swift repricing in AI bets and sending chipmakers and tech names in...
Compare how robo advisor fees stack up against potential returns to help you decide if automation fits your investing plan. This intro explains the core cost-benefit idea in plain terms.
22,067 articlesMoonshot AI unveils the Kimi K3 model, sparking a swift repricing in AI bets and sending chipmakers and tech names in...
A nationwide lettuce recall disrupts menus and weighs on restaurant margins. Investors watch producers and chains as ...
Tilray Brands is set to report on July 28. This article breaks down whether should tilray brands stock be on your rad...
The Digital Chamber filed a lawsuit against Illinois over a 0.2% tax on digital asset transactions, arguing the levy ...
A fresh group of stocks tied to memory chips is redefining global markets as AI data centers push demand higher. The ...
With economic uncertainty builds rising and consumer costs stubborn, Dave Ramsey points to three core moves to weathe...
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Rivian has faced volatility, with a notable pullback this year. This guide breaks down what’s driving the moves, what...
A late-night interview about a political candidate sparked a broader discussion on broadcast rules and money. This ar...
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Saliva-based tests promise easy disease detection, but coverage gaps and costs could slow adoption. Here’s how it cou...
A vast recall affects fried rice sold trader products distributed to Trader Joe's stores across the U.S. and in Canad...